Latest news with #Brenntag
Reuters
6 days ago
- Business
- Reuters
Brenntag confirms profit guidance, cut in July, as market challenges persist
Aug 13 (Reuters) - German chemicals distributor Brenntag ( opens new tab on Wednesday confirmed the annual core profit guidance it had lowered in July, reflecting growing market uncertainty exacerbated by U.S. tariffs and weak dollar. "Economic conditions for the chemical industry and our customer markets remain challenging across the globe," CEO Christian Kohlpaintner said in a statement. "Over the past months, we have seen continued uncertainty, muted customer sentiment, a slowdown in demand and in addition unfavorable EUR/USD exchange results," he said. The group expects operating earnings before interest, taxes and amortisation (EBITA) of 950 million to 1.05 billion euros ($1.11 billion to $1.23 billion) in 2025, down from 1.1 billion euros a year earlier. Brenntag also confirmed the 13.9% drop in its second-quarter operating EBITA to 246.4 million euros, as reported in July. ($1 = 0.8559 euros)
Reuters
6 days ago
- Business
- Reuters
Brenntag confirms 2025 core profit guidance it cut in July
Aug 13 (Reuters) - German chemicals distributor Brenntag ( opens new tab on Wednesday confirmed the annual core profit guidance it had lowered in July due to economic uncertainty and global tariff discussions. The group expects operating earnings before interest, taxes and amortisation (EBITA) of 950 million to 1.05 billion euros ($1.11 billion to $1.23 billion) in 2025, compared to 1.1 billion euros a year earlier. ($1 = 0.8559 euros)
Reuters
6 days ago
- Business
- Reuters
Brenntag cuts core profit guidance for 2025
Aug 13 (Reuters) - German chemicals distributor Brenntag ( opens new tab cut its annual core profit guidance on Wednesday, citing economic uncertainty and global tariff discussions. The group now expects operating earnings before interest, taxes and amortisation (EBITA) of 950 million to 1.05 billion euros ($1.11 billion to $1.23 billion) in 2025, having previously forecast a range of 1.1 billion to 1.3 billion euros. ($1 = 0.8559 euros)
Bloomberg
14-07-2025
- Business
- Bloomberg
Stock Movers: Hermes, AstraZeneca, Brenntag
On this episode of Stock Movers: - Hermes declines as much as 3.3% following a downgrade to hold at Jefferies, which currently doesn't see scope for the French luxury-goods maker to return to peak multiples. Analyst James Grzinic doesn't model any significant acceleration in growth despite firmer US pricing and reduced availability constraints - AstraZeneca's experimental hypertension drug Baxdrostat reduced the blood pressure of patients who have an uncontrolled or treatment-resistant form of the condition, boosting the prospects of the medicine becoming a blockbuster. Astra has identified Baxdrostat as having potential sales of more than $5 billion a year, while Barclays estimates it could bring in about $2 billion a year when taken as a single drug. Shares of AstraZeneca rose as much as 2.1% in early trading in London. - Brenntag shares fall as much as 5.6%, the most in almost two months, after the German chemicals firm cut its earnings guidance for the year in an unscheduled statement on Friday night. Morgan Stanley says underperformance is to be expected today, even if the profit warning wasn't totally surprising.
Fibre2Fashion
25-06-2025
- Business
- Fibre2Fashion
Brenntag expands in Germany with GSZ Kaiserslautern acquisition
Brenntag [ISIN DE000A1DAHH0], the global market leader in chemicals and ingredients distribution, today announced the acquisition of Gefahrstoffzentrum (GSZ) Kaiserslautern GmbH, a toll manufacturing service provider for mixing and blending, filling, storage and logistics of chemical products in South-West Germany. The facility in Kaiserslautern, founded in 2008, will increase Brenntag's local capacity and capabilities for value-added services to regional customers, including mixing and blending, as well as handling and storage of hazardous materials according to the latest and highest safety standards. Brenntag has acquired Gefahrstoffzentrum Kaiserslautern GmbH, a German toll manufacturing service provider. The deal boosts Brenntag's regional capacity for mixing, blending, storage, and handling of hazardous materials, enhancing last-mile services. The Kaiserslautern site, founded in 2008, aligns with Brenntag's safety and service standards. Benjamin Deister, Regional President Brenntag Essential EMEA Central , commented: 'With the facility's state of the art and future-proof capabilities as well as the expertise of the GSZ team we are gaining significant capabilities and services to strengthen our last mile service operations in Germany. We look forward to expanding our product offerings and value-added services to our customers in the region even further with this acquisition.' Dietmar Straub, CEO of Gefahrstoffzentrum Kaiserslautern , added: 'Brenntag recognizes what we have built here over the past 15 years. Striving for safety, excellence and customer service are the key to our past success and align with what Brenntag offers on a global scale. Joining the world leader in chemicals and ingredients distribution, our team in Kaiserslautern will expand the company's horizon and add significant value to Brenntag in Germany.' The company reported sales of approx. 10 million EUR in 2024. Financial details of the deal are not being disclosed. Signing and closing of the transaction occurred simultaneously. Note: The headline, insights, and image of this press release may have been refined by the Fibre2Fashion staff; the rest of the content remains unchanged. Fibre2Fashion News Desk (RM)
